|
|
| CT Healthcare Pty Ltd |
| |
|
CVT Medical is a division of CT Healthcare responsible for developing and marketing the company’s Cyclo-Massage® technology that provides a credible, proven treatment for the medical resolution of ailments from lymphatic and circulatory disorders.
CT Healthcare has been operating in the Australasian region since 1969 and has been manufacturing TGA-approved medical devices in Australia since 1983. The operation has significant capacity to supply export markets in Europe, USA and South East Asia.
CVT Medical is seeking specialist medical device distributors to market Lymphease® to the health and medical community in the following markets: Germany, England, Ireland, Scotland, Wales, Spain, France and Italy.
CVT Medical has developed Lymphease® a patented medical device for a self administered treatment protocol underpinned by scientific validation of the efficacy of Cycloidal Vibration as an enabling technology that resolves the symptoms of Lymphoedema by stimulating lymphatic drainage.
Cyprossage Pty Ltd holds global design and technology patents on the Lymphease® product. Competitive Advantages
"Cycloid vibrational massage of 30 minutes duration, whether intermittent or continuous, significantly increases tissue fluid drainage from sub-dermal tissues, probably due to the increase in tissue pressure that this massage causes."
"The optimal vibration protocol appears to be cycloid vibration at low - moderate frequency, with low - moderate force."
"Cycloid vibration has an enormous local and world wide potential in the management of existing diseases and disorders which affect the blood tissue lymph systems. The combination of the prior clinical data and the broad based experimental trial which informed us of the mode of action of the cycloid vibration and indicated strongly the optimal frequency, amplitude, duration and pressure is the basis of the science behind the cycloid vibration."
Professor Neil Piller, Flinders University Report www.lymphease.com
 
| |
|
|
|
|
|
|
|
|
|
|